This path-breaking book addresses the ongoing implications for traditional pharmaceutical companies and biopharmaceutical start-ups of the realignment of the industry knowledge-base. The theoretical approach draws on the modern theory of the firm and related ideas in order to better define the...

Nanotechnology is the latest in a series of general purpose technologies (GPT), earlier examples of which, have transformed household life, industry structure and firm performance. This paper traces the development to date of one of the first uses of nanotechnology to synthesise a new drug....

This study addresses the ongoing implications of the realignment of the pharmaceutical industry knowledge base ? from small molecule methods to new biomedical technologies ? for the competitive positions of traditional pharmaceuticalcompanies and biopharmaceutical start-ups. The theoretical...

Executive summary: This report documents the continuing growth and transition of the Western Region identified in the 2004 report by the Centre for Strategic Economic Studies (Sheehan and Wiseman 2004). It follows a number of reports about the Region (NIEIR 2004; LeadWest 2008), in each of which...

Using the framework of the business model developed in Rasmussen (2007b) this paper presents an outline of the traditional pharmaceutical company business model, and how it has responded to the new biotechnology. Biotechnology is a radical innovation which has a very different technological...

The concept of a business model facilitates analysis of the way in which a firm derives economic value from a newly developed technology. Indeed Chesbrough and Rosenbloom (2002) have argued that it is the business model adopted, more so than the technology itself, which is critical to the...

The resource based view of Wernerfelt (1984), Barney (1986, 1991) and Deirickx and Cool (1989) suggests that firms can achieve sustainable competitive advantage through the accumulation of strategic assets that are hard to imitate, substitute or trade (Amit and Schoemaker 1993). It is also...